Natco Pharma share price
You have to be logged in to add this to Watchlist.Natco Pharma is trading 0.97% upper at Rs 1,369.20 as compared to its last closing price. Natco Pharma has been trading in the price range of 1,383.50 & 1,355.45. Natco Pharma has given 67.33% in this year & -0.68% in the last 5 days.
Natco Pharma has TTM P/E ratio 13.08 as compared to the sector P/E of 33.29.There are 8 analysts who have initiated coverage on Natco Pharma. There are 1 analysts who have given it a strong buy rating & 2 analysts have given it a buy rating. 2 analysts have given the stock a sell rating.
The company posted a net profit of 677.30 Crores in its last quarter.
Listed peers of Natco Pharma include JB Chemicals & Pharmaceuticals (0.96%), Laurus Labs (3.84%), Natco Pharma (0.97%) etc.
Natco Pharma has a 50.38% public holding.The Mutual Fund holding in Natco Pharma was at 2.37% in 30 Sep 2024. The MF holding has decreased from the last quarter. The FII holding in Natco Pharma was at 17.51% in 30 Sep 2024. The FII holding has increased from the last quarter.
Natco Pharma share price range
|
| ||||
|
| ||||
Natco Pharma share Key Metrics
| Market Cap ( ₹ Cr.) | 24,315.96 | ||||||||||||||||||
|
|
Technical Trends
Long TermConsiders price movement over the last 6 months
Short TermConsiders price movement over the last 1-2 weeks
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Natco Pharma Corporate actions
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
| 12-Nov-24 | Quarterly Results & Interim Dividend |
| 12-Aug-24 | Quarterly Results & Interim Dividend |
| 27-May-24 | Audited Results |
| 14-Feb-24 | Quarterly Results & Interim Dividend |
| 14-Nov-23 | Quarterly Results & Interim Dividend |
| 09-Aug-23 | Quarterly Results & Interim Dividend |
| 29-May-23 | Audited Results |
| 08-Mar-23 | Buy Back of shares |
| 09-Feb-23 | Quarterly Results & Interim Dividend |
| 10-Nov-22 | Quarterly Results & 2nd Interim Dividend |
| Meeting Date | Announcement On | Purpose |
| 28-Mar-24 | 22-Feb-24 | POM |
| 29-Sep-23 | 05-Sep-23 | AGM |
| 27-Mar-22 | 22-Feb-22 | POM |
| - | 12-Aug-24 | AGM |
| Announcement On | Record Date | Ex-Dividend | Dividend Value |
| 12-Nov-24 | 27-Nov-24 | 27-Nov-24 | 1.5 |
| 12-Aug-24 | 23-Aug-24 | 23-Aug-24 | 3 |
| 14-Feb-24 | 26-Feb-24 | 26-Feb-24 | 1.25 |
| 15-Nov-23 | 24-Nov-23 | 24-Nov-23 | 1.25 |
| 09-Aug-23 | 22-Aug-23 | 22-Aug-23 | 7 |
| 09-Feb-23 | 21-Feb-23 | 21-Feb-23 | 1.25 |
| 10-Nov-22 | 22-Nov-22 | 21-Nov-22 | 0.75 |
| 10-Aug-22 | 22-Aug-22 | 19-Aug-22 | 3.5 |
| 14-Feb-22 | 25-Feb-22 | 24-Feb-22 | 2 |
| 11-Nov-21 | 24-Nov-21 | 23-Nov-21 | 0.5 |
FAQs about Natco Pharma share price
Natco Pharma is trading at 1369.20 as on Mon Nov 25 2024 09:59:00. This is 0.97% upper as compared to its previous closing price of 1356.00.
The market capitalization of Natco Pharma is 24315.96 Cr as on Mon Nov 25 2024 09:59:00.
The average broker rating on Natco Pharma is Hold. The breakup of analyst rating is given below -
- 1 analysts have given a strong buy rating
- 2 analysts have given a buy rating
- 2 analysts have given a hold rating
- 2 analysts have given a sell rating
- 1 analysts have given a strong sell rating
The 52 wk high for Natco Pharma is 1638.35 whereas the 52 wk low is 752.55
Natco Pharma can be analyzed on the following key metrics -
- TTM P/E: 13.08
- Sector P/E: 33.29
- Dividend Yield: 0.42%
- D/E ratio: 0.03
Natco Pharma reported a net profit of 1388.30 Cr in 2024.
Natco Pharma Quick Links
Natco Pharma Dividend Natco Pharma Bonus Natco Pharma News Natco Pharma AGM Natco Pharma Rights Natco Pharma Splits Natco Pharma Board Meetings Natco Pharma Key Metrics Natco Pharma Shareholdings Natco Pharma Profit Loss Natco Pharma Balance Sheet Natco Pharma Cashflow Natco Pharma Q1 Results Natco Pharma Q2 Results Natco Pharma Q3 Results Natco Pharma Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks